中文|English

Current issue
2024-3-25
Vol 32, issue 3

ISSUE

2024 年3 期 第32 卷

医学循证 HTML下载 PDF下载

中国脑胶质瘤患者术后发生癫痫危险因素的 Meta 分析

Risk Factors of Postoperative Epilepsy in Glioma Patients in China: a Meta-analysis

作者:梁新慧1,2 ,贾瑶2 ,胡梦依1 ,刘芳1 ,姜雪2

单位:
1.712046陕西省咸阳市,陕西中医药大学护理学院 2.710038陕西省西安市,空军军医大学第二附属医院 神经外科
Units:
1.College of Nursing, Shaanxi University of Chinese Medicine, Xianyang 712046, China 2.Department of Neurosurgery, the Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, China
关键词:
神经胶质瘤;癫痫;危险因素;Meta分析
Keywords:
Glioma; Epilepsy; Risk factors; Meta-analysis
CLC:
R 730.264 R 742.1
DOI:
10.12114/j.issn.1008-5971.2024.00.006
Funds:
军队护理创新与培育专项计划创新项目(2021HL041)

摘要:

目的 系统评价中国脑胶质瘤患者术后发生癫痫的危险因素。方法 计算机检索PubMed、Web of Science、Cochrane Library、Embase、中国知网、万方数据知识服务平台、维普网、中国生物医学文献数据库公开 发表的中国脑胶质瘤患者术后发生癫痫危险因素的文献。检索时限为建库至2023年5月。提取纳入文献的资料, 病例对照研究和队列研究文献质量采用纽卡斯尔-渥太华量表(NOS)进行评价,采用RevMan 5.4软件进行Meta 分析。结果 本研究纳入16篇文献,共3 612例患者,其中癫痫组592例、对照组3 020例。Meta分析结果显示,术 前癫痫发作频率≥1次/d〔OR=2.78,95%CI(1.84~4.91)〕、有癫痫病史〔OR=5.42,95%CI(4.23~6.93)〕、 术前有运动障碍〔OR=5.56,95%CI(3.31~9.33)〕、术前未预防用药〔OR=6.75,95%CI(3.11~14.65)〕、 额颞叶肿瘤〔OR=2.39,95%CI(1.41~4.05)〕、低级别脑胶质瘤〔OR=5.24,95%CI(3.27~8.39)〕、肿瘤 直径≥5 cm〔OR=5.20,95%CI(2.32~11.66)〕、部分切除〔OR=8.76,95%CI(3.57~21.46)〕、术后瘤周 水肿〔OR=2.96,95%CI(1.45~6.03)〕、术后瘤周水肿≥2 cm〔OR=4.85,95%CI(2.45~9.57)〕、术后瘤 腔出血〔OR=3.30,95%CI(1.82~5.99)〕、术后未预防用药〔OR=8.36,95%CI(3.30~21.18)〕、肿瘤复 发〔OR=4.02,95%CI(2.31~6.98)〕是中国脑胶质瘤患者术后发生癫痫的危险因素(P<0.05)。结论 现有证据显 示,术前癫痫发作频率≥1次/d、有癫痫病史、术前有运动障碍、术前未预防用药、额颞叶肿瘤、低级别脑胶质瘤、肿 瘤直径≥5 cm、部分切除、术后瘤周水肿、术后瘤周水肿≥2 cm、术后瘤腔出血、术后未预防用药、肿瘤复发是中国 脑胶质瘤患者术后发生癫痫的危险因素。

Abstract:

 Objective To systematically evaluate the risk factors of postoperative epilepsy in glioma patients in China. Databases including the PubMed, Web of Science, Cochrane Library, Embase, CNKI, Wanfang Data, VIP, CBM were retrieved to search for studies on the risk factors of postoperative epilepsy in glioma patients in China from inception to May 2023. The data of the included literature were extracted, the Newcastle-Ottawa Scale was used to evaluate the quality of the case-control studies and cohort studies. RevMan 5.4 was used for meta-analysis. Results A total of 16 articles were included, and involving 3 612 patients, including 592 cases in epilepsy group and 3 020 cases in control group. Meta-analysis results showed that frequency of preoperative epilepsy ≥ 1 time/day [OR=2.78, 95%CI (1.84-4.91) ] , history of epilepsy [OR=5.42, 95%CI (4.23-6.93) ] , preoperative dyskinesia [OR=5.56, 95%CI (3.31-9.33) ] , unperotected medication before surgery [OR=6.75, 95%CI (3.11- 14.65) ] , frontal and temporal lobe tumors [ OR=2.39, 95%CI (1.41-4.05) ] , low-grade glioma [ OR = 5.24, 95 % CI (3.27-8.39) ] , tumor diameter ≥ 5 cm [OR=5.20, 95%CI (2.32-11.66) ] , partial resection [ OR=8.76, 95 %CI (3.57-21.46) ] , postoperative peritumoral edema [OR=2.96, 95%CI (1.45-6.03) ] , postoperative peritumoral edema ≥ 2 cm [ OR = 4.85, 95 % CI (2.45-9.57) ] , postoperative intratumoral hemorrhage [OR=3.30, 95%CI (1.82-5.99) ] , unprotected medication after surgery [OR=8.36, 95%CI (3.30-21.18) ] , tumor recurrence [OR=4.02, 95%CI (2.31-6.98) ] were the risk factors of postoperative epilepsy in glioma patients in China (P < 0.05) . Conclusion The available evidence shows that the frequency of preoperative epilepsy ≥ 1 time/day, history of epilepsy, preoperative dyskinesia, unperotected medication before surgery, frontal and temporal lobe tumors, low-grade glioma, tumor diameter ≥ 5 cm, partial resection, postoperative peritumoral edema, postoperative peritumoral edema ≥ 2 cm, postoperative intratumoral hemorrhage, unprotected medication after surgery, tumor recurrence are the risk factors of epilepsy in glioma patients in China.

ReferenceList: